About Us
Welcome TO TAC Biopharmaceuticals LLC
Where excellence in the Biotechnology and Pharmaceutical Arena is not just a goal, but a relentless commitment. With a team boasting robust scientific, technical, and regulatory expertise, along with a vast international network and a proven track record, we stand poised to be your trusted partner on the path to Biopharmaceutical success.
At TAC Biopharmaceuticals, we offer a comprehensive range of specialized services designed to empower and guide your Biotechnology and Pharmaceutical endeavors. We excel at connecting the dots, ensuring you have the right end-to-end solutions to tackle the challenges of modern medicine development and commercialization.
Whether you're a startup, delving into Generic Drugs, exploring Biosimilars, or navigating complex Technological processes, our expertise is here to support you every step of the way from development to commercialization.
Backed by MD, PharmD, Molecular and Clinical Pharmacology and Business backgrounds, our team brings over 25 years of hands-on experience in the biotechnology and pharmaceutical industry. This includes spearheading the development of manufacturing facilities from the ground up and developing over 70 Generic Drugs and 6 Biosimilars.
Choose TAC Biopharmaceuticals for unparalleled expertise, unwavering dedication, and a proven track record of success in the ever-evolving landscape of Biotechnology and Pharmaceutical innovation.
Strategy and Business Development
Strategy to Execution
TAC Biopharmaceuticals is dedicated to propelling your success through strategic vision and business development. We offer a range of services to drive growth and innovation within the biopharmaceutical sector
- Strategy development for Market access and entry
- Competitive analysis
- Strategic partnerships
- Product portfolio optimization
- Commercialization Planning
- Feasibility study
Market Evaluation and Access
Smart Positioning
Comprehensive Market Evaluation and Access services, ensuring your products achieve optimal market penetration
- Portfolio evaluation and product prioritization
- Market expansion and forecasting
- Competitive analysis
- Cost-effectiveness and Health Economics analysis
- Pricing strategy
Regulatory Services
Compliance to Success
Our regulatory services are designed to empower your biopharmaceutical endeavors, from early development to market access, ensuring compliance and success every step of the way.
- Regulatory strategy
- Abbreviated New Drug Application(ANDA) Submissions
- Biologics license Application (BLA) Submissions
- Drug Master File (DMF) Submissions
- New Drug Application (NDA) Submissions
- Investigational New Drug (IND) Submissions
- Post-Approval Changes
- Regulatory Compliance
- Inspection readiness and GxP Compliance
- FDA Communications
- Risk Assessment
- Labeling
- Regulatory Intelligence
- Post-Market support
Sales and Distribution
Reach the Market
We are committed to optimizing your product's sales and distribution strategies in the ever-evolving biopharmaceutical industry
- Import / Export setup
- Distribution network development
- Channel partner management
- Sales forecast
Turkish Products Distribution
Supplying the world
As an expert group in the field, we propose well-documented, high-quality (EU-standard) Turkish pharmaceuticals at competitive prices for emerging markets.
The Turkish pharmaceutical industry has a long-standing tradition of high-quality production, with EU-approved manufacturing facilities that fully compatible to the latest European standards in technology, capacity, documentation, and quality assurance. Turkey has been a member of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) since 2018—alongside the U.S., Germany, Australia, Switzerland, Japan, and Canada—and a regulatory member of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) since 2020. These global memberships ensure that pharmaceutical products manufactured and approved in Turkey meet internationally recognized quality and regulatory standards.
With 81 production facilities, approximately 500 pharmaceutical companies, and over 35,000 employees, the Turkish pharmaceutical industry manufactures more than 11,000 products. In recent years, the industry has demonstrated strong export growth, reaching $1.92 billion in 2022 and $2.23 billion in 2023, with a significant portion of exports directed to Europe, Asia, and the Middle East.
We are actively seeking reliable partners to establish long-term collaborations. Our goal is to introduce, register, and commercialize high-quality Turkish pharmaceutical products, ensuring accessibility to affordable and well-documented medicines.
Get in touch with us directly if you have any questions or require further information.
Legal Consulting
Protect your assets
Our Legal consulting is designed to safeguard your biopharmaceutical ventures, ensuring legal compliance and protecting your valuable assets while navigating the complex legal landscape of the industry
- Legal Entity establishment
- Intellectual Property Evaluation
- Contract Negotiations
- Licensing and Collaborative Agreements